Home
About
Overview
Sharing Data
ORCID
Help
History (42)
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era.
Feasibility of implementing a comprehensive warfarin pharmacogenetics service.
Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
Genetic testing in diverse populations: are researchers doing enough to get out the correct message?
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
See All 42 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway. Clin Cancer Res. 2017 Feb 15; 23(4):1091-1103.
View in:
PubMed
subject areas
Animals
Breast Neoplasms
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Humans
Interleukin-11
Mice
Microfilament Proteins
MicroRNAs
Neoplasm Metastasis
Neoplastic Stem Cells
Protein-Tyrosine Kinases
Serum Response Factor
Signal Transduction
Trans-Activators
Xenograft Model Antitumor Assays
authors with profiles
Dezheng Huo